跳至主要内容
临床试验/JPRN-UMIN000001030
JPRN-UMIN000001030已完成4 期

Clinical relevance of microalbuminuria and intra-renal RAS in metabolic sydrome patients. - Effect of olmesartan on microalbuminuria and intrarenal RAS - - A multicenter study on the effect of olmesartan on intrarenal RAS in metabolic syndrome patients.

Kagawa University, Faculty of Medicine0 个研究点目标入组 100 人开始时间: 2008年2月13日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Pregnancy 2) Patient who has been treated with ARB, ACEI or diuretics within 4 weeks 3) Patient with diabetes mellitus who treats with anti-diabetic drugs 4) Severe hypertension (SBP >= 160 mmHg or DBP >= 110 mmHg) 5) Secondary hypertension 6) Severe renal disease (UACR>300 mg/g, CCr<30 mL/min, sCr >= 2.0 mg/dL) 7) Severe hepatic disease (GOT >= 150 IU or GPT >= 150 IU) 8) History of major cardiac or cerebrovascular events 9) Endocrine disease 10) Patients with malignant tumor 11) Patients inadequate for the study

研究者

发起方
Kagawa University, Faculty of Medicine

相似试验